Development of natural immunity to Neisseria meningitidis (Q34133149)

31 July 2017

1 reference

title

Development of natural immunity to Neisseria meningitidis (English)

1 reference

31 July 2017

Neisseria meningitidis

1 reference

Pollard AJ

1

1 reference

PubMed ID

11163654

31 July 2017

Frasch C

series ordinal

2

1 reference

PubMed ID

11163654

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

19

1 reference

31 July 2017

11-12

1 reference

31 July 2017

1327-1346

1 reference

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Epidemiology and prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The Changing Epidemiology of Meningococcal Disease in the United States, 1992–1996

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human immunity to the meningococcus. II. Development of natural immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Meningococcal phenotypic and genotypic characteristics and human antibody levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Structural studies of the Escherichia coli K93 and K53 capsular polysaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Serum bactericidal activity in a secondary school population following an outbreak of meningococcal disease: effects of carriage and secretor status

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Meningococcemia caused by serogroup W135. Association with hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Gamma-M deficiency predisposing to meningococcal septicaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Risk of group A meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Efficacy of meningococcal vaccine and barriers to vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Meningococcal vaccines. Current status and future possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Control of meningococcal infection in the African meningitis belt by selective vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Recent Knowledge of the Incidence and Control of Cerebrospinal Fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immune response of infants and children to disseminated infections with Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The immune response to the capsular polysaccharide of Neisseria meningitidis group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Cross-reactivity of Neisseria gonorrhoeae and Neisseria meningitidis and the nature of antigens involved in the bactericidal reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Serum antibodies to cross-reactive Neisseria outer membrane antigens in healthy persons and patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Vaccines for prevention of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Role of Protein Serotype Antigens in Protection against Disease Due to Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human immune response to epitopes on the meningococcal outer membrane class 5 protein following natural infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Invasive isolates of Neisseria meningitidis possess enhanced immunoglobulin A1 protease activity compared to colonizing strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The Neisseria type 2 IgA1 protease cleaves LAMP1 and promotes survival of bacteria within epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Blocking of iron uptake from transferrin by antibodies against the transferrin binding proteins in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Analysis of the human Ig isotype response to lactoferrin binding protein A from Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Response of Neisseria meningitidis to iron limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Coordination of iron by the ferric iron-binding protein of pathogenic Neisseria is homologous to the transferrins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

For discussion: live attenuated vaccines for group B meningococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Meningitis bacterium is viable without endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibodies to meningococci in children with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Meningococcal bacteremia: clinical and serologic studies of infants with mild illness

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Neisseria meningitidis and Neisseria gonorrhoeae Bacteremia Associated with C6, C7, or C8 Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Complement factor 9 deficiency in serum of human neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Recognition and control of neisserial infection by antibody and complement.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Association of low levels of mannan-binding protein with a common defect of opsonisation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Mannose-binding lectin: the pluripotent molecule of the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

A Low Serum Concentration of Mannan-Binding Protein is Not Associated with Serogroup B or C Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Isolation and characterization of a mannan-binding protein from rabbit liver

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

A second serine protease associated with mannan-binding lectin that activates complement

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The human mannose-binding protein functions as an opsonin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The effect of mannan-binding lectin on opsonophagocytosis of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Mannose binding protein gene mutations associated with unusual and severe infections in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Adherence and hydrophobicity in Neisseria meningitidis and their relationship with surface charge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Effect of smoking on meningococcal carriage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Host cell invasion by pathogenic Neisseriae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Secretor status and humoral immune responses to Neisseria lactamica and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Bactericidal Antibody after Colonization with Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Cross-reacting serum opsonins in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Cross-Antigenicity and Immunogenicity between Capsular Polysaccharides of Group C Neisseria meningitidis and of Escherichia coli K92

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antigenic Relationship between Escherichia coli and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Current status of lactose-fermenting Neisseria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The interaction in vitro between group B meningococci and rabbit polymorphonuclear leukocytes. Demonstration of type specific opsonins and bactericidins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Ultrastructural studies on the fate of group B meningococci in human peripheral blood leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Biochemical, structural, and functional abnormalities of polymorphonuclear leukocytes in the neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Phenotypic variants of meningococci and their potential in phagocytic interactions: the influence of opacity proteins, pili, PilC and surface sialic acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Neutrophil response to Neisseria meningitidis: inhibition of adhesion molecule expression and phagocytosis by recombinant bactericidal/permeability-increasing protein (rBPI21)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Postnatal maturation of immune competence during infancy and childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Production of lymphotoxin and tumor necrosis factor by human neonatal mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Phagocytosis-associated functions in neonatal monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

IgA-dependent, monocyte-mediated, antibacterial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. II. Immune specificity of antimeningococcal activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

The role of soluble factors in T-B cell collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

T cell independent antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

T cell-independent antigens type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

T-cell modulation of the antibody response to bacterial polysaccharide antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

T-cell modulation of the murine antibody response to Neisseria meningitidis group A capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immune Response of Human Infants to Polysaccharide Vaccines of Groups A and C Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

T-cell responses to outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Opc, and PorA proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Cellular immune responses to Neisseria meningitidis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Murine cross-reactive T-cell epitopes of Neisseria meningitidis outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Polyclonal activation of human peripheral blood lymphocytes by bacterial porins and defined porin fragments.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Polyclonal activation of murine B lymphocytes in vitro by Salmonella typhimurium porins.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Sialylation and human neutrophil killing of group C Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Meningococcal molecular mimicry and the search for an ideal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that r

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Expression of the Opc protein correlates with invasion of epithelial and endothelial cells by Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Vaccine potential of meningococcal FrpB: studies on surface exposure and functional attributes of common epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

Purification and characterization of the major iron-regulated protein expressed by pathogenic Neisseriae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900333-9

7 January 2021

10.1016/S0264-410X(00)00333-9

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11163654